M. Moshiashvili

发表

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

G. Shefer, D. Hagin, R. Eshel, 2021, Transplantation and Cellular Therapy.

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy — A Single-Center Prospective Cohort Study Transplantation and Cellular Therapy

G. Shefer, D. Hagin, R. Eshel, 2021 .